Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 1 - 50 out of 7,139

Document Document Title
WO/2020/189391A1
The present invention pertains to: a scytalone dehydratase inhibitor which contains at least one compound selected from the compounds represented by formula (I) (in the formula, A1-A4 each represents CH or N; R is a substituent other tha...  
WO/2020/191091A1
This invention provides for compounds of the formula wherein the variables are defined herein, or a stereoisomer, tautomer, N-oxide, hydrate, solvate, or salt thereof, compositions comprising these compounds, and method for the treatment...  
WO/2020/188437A1
The present invention relates to compounds with a 5-(2-nitroethyI)-2,4,6- triaminopyrimidine structure, derivatised at the 1 position on the ethylene chain with heteroaromatic or phenyl-benzylether rings. The invention also relates to th...  
WO/2020/188183A1
The invention relates to a process for producing a polybenzoxazine monomer, the crosslinking thereof, and the use of the crosslinked product to form ablative thermal protection for a propelling nozzle or a body for atmospheric re-entry.  
WO/2020/188182A1
The invention relates to a process for producing a polybenzoxazine monomer, the crosslinking thereof and the use of the crosslinked product to form an ablative thermal protection for a thruster nozzle or an atmospheric re-entry body.  
WO/2020/185420A1
Provided herein are integrated methods and systems for the production of acrylamide and acrylonitrile compounds and other compounds from at least beta-lactones and/or beta-hydroxy amides.  
WO/2020/178404A1
The present invention relates to herbicidally active pyridazine derivatives of Formula (I) as defined herein, as well as to herbicidal compositions comprising such derivatives, and the use of such compounds and compositions for controlli...  
WO/2020/176505A1
The present disclosure relates generally to certain diacylglycerol lactone compounds, pharmaceutical compositions comprising said compounds, and methods of making and using said compounds and pharmaceutical compositions. The compounds an...  
WO/2020/175688A1
[Problem] To provide a fluorescent probe capable of detecting breast cancer, lung cancer, and squamous cell cancer. [Solution] A fluorescent probe for detecting breast cancer and benign tumors of the breast, the probe containing a compou...  
WO/2020/172258A1
Disclosed herein are compounds and compositions having potency in the modulation of Myc family proteins. Such compounds and compositions can be used in the treatment of proliferative diseases, such as cancer, or in the treatment of disea...  
WO/2020/168149A1
Disclosed are compounds of Formula (I): or a stereoisomer, a tautomer, or a pharmaceutically acceptable salt or solvate thereof, wherein Q is: (i) halo, cyano, hydroxyl, NRxRx, C(O)OH, C(O)NH2, C1-6 alkyl substituted with zero to 6 R1a, ...  
WO/2020/166875A1
The present invention provides a novel compound and an organic light emitting device using same.  
WO/2020/166874A1
The present invention provides a novel compound and an organic light-emitting diode using same.  
WO/2020/156363A1
The present application discloses an immunomodulator, and specifically discloses a compound depicted by formula (I), or a stereoisomer thereof, or a pharmaceutically acceptable salt thereof. The compound provided in the present applicati...  
WO/2020/117366A3
A composition of matter including two optionally substituted phenol or optionally substituted aniline units separated by a furan spacer has been prepared. In particular, the chemical structure has a novolac bridge between the central fur...  
WO/2020/159019A1
The present invention relates to a novel organic light-emitting compound and an organic electroluminescent device using same and, more specifically, to a compound having excellent thermal stability, electrochemical stability, light-emitt...  
WO/2020/158958A1
The present invention provides a heterocyclic compound having an orexin type 2 receptor agonist activity. A compound represented by the formula (I): wherein each symbol is as described in the specification, or a salt thereof has an orexi...  
WO/2020/152067A1
Compounds of the formula (I): Q1-Q2-Q3, in which Q1, Q2 and Q3 have the meanings indicated in Claim 1, degrade target proteins, and can be employed, inter alia, for the treatment of diseases such as cancer, multiple sclerosis, cardiovasc...  
WO/2020/127259A3
The present application concerns compounds for use in electronic devices, processes for preparing the compounds, and electronic devices comprising the compounds.  
WO/2020/151623A1
The present invention pertains to the medical field and relates to a compound of formula (III), a stereoisomer or pharmaceutically acceptable salt thereof. The present invention also relates to a method for preparing the compound, a ster...  
WO/2020/151621A1
The present invention belongs to the field of medicine, and specifically relates to a compound of formula (I), an isomer or a pharmaceutical salt thereof. This present invention more specifically relates to a compound, a stereoisomer the...  
WO/2020/153669A1
The present invention relates to a compound for an organic electric device, an organic electric device using same, and an electronic apparatus thereof. According to the present invention, high luminous efficiency, low driving voltage, an...  
WO/2020/076274A3
The present invention is related to unique caffeic acid phenethyl ester (CAPE) analogues, methods for preparation of said molecules, and the usage of said unique molecules in the preparation of a pharmaceutical composition that is to be ...  
WO/2020/135427A1
The present invention relates to a monomer compound represented by formula (I), wherein each variable is as defined in the description. The described monomer is quickly synthesized at a high yield by means of a click chemistry reaction b...  
WO/2020/139001A1
The present invention provides a novel aryl-substituted aminomethyloxetenyl amino alcohol derivative or a pharmaceutically acceptable salt thereof. More specifically, the derivative has an effect of promoting ATP production and as such, ...  
WO/2020/135872A1
Provided are a drug, a pharmaceutical composition, or a pharmaceutical kit for immunosuppression, for the treatment of conditions such as psoriasis, comprising a forskolin derivative or a salt thereof and optionally a prostaglandin compo...  
WO/2020/138732A1
The present invention provides: a compound represented by chemical formula 1; an organic electric device comprising a first electrode, a second electrode, and an organic material layer between the first electrode and the second electrode...  
WO/2020/134138A1
The present disclosure relates to the technical field of luminescent materials, and relates in particular to an organic electroluminescent compound, a preparation method therefor and an organic electroluminescent device. In order to solv...  
WO/2020/131689A1
Provided herein is a compound of Formula (I), or a salt thereof, wherein R1 is a moiety having the following structure: (II) wherein Z is selected from the group consisting of O and N; X is selected from the group consisting of a bond, N...  
WO/2020/127259A2
The present application concerns compounds for use in electronic devices, processes for preparing the compounds, and electronic devices comprising the compounds.  
WO/2020/127194A1
Anticancer compounds of formula (I) and derivatives thereof are provided.  
WO/2020/132278A1
The present invention concerns the use of compounds and compositions for the treatment or prevention of Flavivirus infections, such as dengue virus infections and Zika virus infections. Aspects of the invention include methods for treati...  
WO/2020/127200A1
The present invention relates to a compound of formula (I), optionally in the form of a pharmaceutically acceptable salt, solvate, cocrystal, tautomer, racemate, enantiomer, or diastereomer or mixture thereof Formula (I) and to pharmaceu...  
WO/2020/130102A1
Antibody preparations for improving or treating autoimmune diseases have been proposed, but the route of administration is limited to intravenous, imposing a burden on the patient. Also, mangiferin has an effect for improving autoimmune ...  
WO/2020/120528A1
The present invention provides the compounds having the general formula: (I) wherein R1 to R8, and X are as described herein, compositions including the compounds and methods of using the compounds.  
WO/2020/122908A1
An electrochromic medium for use in an electro-optic device comprises a solvent comprising at least one low-volatile organic electrolyte solvent based on a cyclic carbonate ester; an anodic electroactive material; and a cathodic electroa...  
WO/2020/117894A1
Enantioselective total syntheses of the anticancer isocarbostyril alkaloids (+)-7-deoxypancratistatin, (+)-pancratistatin, (+)-lycoricidine, and (+)-narciclasine are described. Our strategy for accessing this unique class of natural prod...  
WO/2020/118116A1
The present disclosure provides NIR- and SWIR-active small molecule polymethine dyes with improved properties for use in optical imaging, photothermal therapy, and photodynamic therapy.  
WO/2019/161157A8
Provided are compounds of Formula (I): and pharmaceutically acceptable salts and compositions thereof, which are useful for treating a variety of conditions associated with histone acetyltransferase (HAT).  
WO/2020/110008A1
The disclosure relates to inhibitors of PCSK9 useful in the treatment of cholesterol lipid metabolism, and other diseases in which PCSK9 plays a role, having the Formula (I):, or a pharmaceutically acceptable salt, hydrate, solvate, prod...  
WO/2020/111613A1
The present invention provides a novel compound and an organic light-emitting diode using same.  
WO/2020/111602A1
The present invention provides a novel compound and an organic light-emitting element using same.  
WO/2020/111586A1
The present invention provides a novel compound and an organic light-emitting device using same.  
WO/2020/111584A1
The present invention provides a novel compound and an organic light emitting diode using same.  
WO/2020/111601A1
The present invention provides a novel compound and an organic light-emitting device using same.  
WO/2020/111780A1
The present invention provides a novel compound and an organic light emitting device using same.  
WO/2020/111585A1
The present invention provides a novel compound and an organic light-emitting device using same.  
WO/2020/111673A1
The present invention provides a novel compound and an organic light emitting diode using same.  
WO/2020/111225A1
Provided are: a triazine compound having a high glass transition temperature, the triazine compound contributing to the formation of an organic electroluminescent element that exhibits high luminous efficiency and long service life chara...  
WO/2020/106028A1
The present specification provides a compound represented by chemical formula 1 and an organic light-emitting device comprising same.  

Matches 1 - 50 out of 7,139